The 30-day risks of hospitalization were 17.5%, 15.9%, and 14.4% for COVID, influenza, and RSV, respectively, during the 2022 ...

Respiratory Syncytial Virus (RSV) is a highly contagious respiratory illness that primarily affects infants and older adults, ...

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

At the start of every week, our team talks with local experts to unpack a wide range of nationwide health, safety, and ...

Human Metapneumovirus (HMPV) is a respiratory virus that may not be on most folk’s radars, but it’s more common than you ...

RSV is usually contagious for three to eight days. A patient also may be contagious a day or two before experiencing symptoms ...

As winter settles in, respiratory illnesses such as COVID-19, flu, and RSV are on the rise, particularly in recent months.

Respiratory viruses are continuing to spread across the United States and such activity "is expected to continue for several ...

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

Respiratory illness levels, including COVID, RSV and flu are increasing nationwide, according to Sanford Health and the CDC.